Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices 69091 

Contact Person: Philippe Marmillot, PhD, 

Scientific Review Officer, National Institutes 

of Health, National Institute on Alcohol 

Abuse and Alcoholism, 5635 Fishers Lane, 

Room 2019, Bethesda, MD 20892, 301–443– 

2861, marmillotp@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards., National 

Institutes of Health, HHS) 

Dated: November 3, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28376 Filed 11–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 USC, 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Clinical Treatment and 

Health Services Research Review 

Subcommittee. 

Date: March 15–16, 2011. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, 7400 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Katrina Foster, PhD, 

Scientific Review Officer, National Institute 

on Alcohol Abuse and Alcoholism, National 

Institutes of Health, 5635 Fishers Lane, Room 

2019, Rockville, MD 20852, 301–443–4032, 

katrinaf@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: November 3, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28374 Filed 11–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, Office of 

Biotechnology Activities; Notice of 

Meeting 

There will be a workshop entitled 

‘‘Retroviral and Lentiviral Vectors for 

Long-Term Gene Correction: Clinical 

Challenges in Vector and Trial Design.’’ 

The meeting will be open to the public; 

attendance is limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Recombinant DNA 

Advisory Committee. 

Date: December 9, 2010. 

Time: 8 a.m. to 5:30 p.m. 

Date: December 10, 2010. 

Time: 8 a.m. to 1 p.m. 

Agenda: The Office of Biotechnology 

Activities (OBA), NIH Recombinant DNA 

Advisory Committee and the European 

Network for the Advancement of Clinical 

Gene Transfer (CliniGene) will host a 

workshop on Retroviral and Lentiviral 

Vectors for Long-Term Gene Correction: 

Clinical Challenges in Vector and Trial 

Design at the Bethesda Marriott on December 

9 and 10, 2010. The meeting will cover the 

following topics: Developments in retrovirus 

and lentivirus integration and insertional 

mutagenesis research, including nonenhancer mediated mechanisms of 

insertional mutagenesis; modifications to 

retroviral and lentiviral vectors to enhance 

their safety; research on in vitro and animal 

models to evaluate the safety of human gene 

transfer; and ethical issues in the design of 

new clinical trials. The agenda is posted to 

OBA’s Web site: http://oba.od.nih.gov/ 

rdna_rac/rac_meetings.html. Please check 

the meeting agenda for more information. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, Maryland 20814. 

Contact Person: Chezelle George, Program 

Assistant, Office of Science Policy, Office of 

Biotechnology Activities, National Institutes 

of Health, 6705 Rockledge Drive, Suite 750, 

Bethesda, MD 20892, 301–496–9838, 301– 

496–9839, georgec@mail.nih.gov. 

Any interested person may file written 

comments with the panel by forwarding the 

statement to the Contact Person listed on this 

notice. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

Background information may be obtained by 

contacting NIH OBA by e-mail 

oba@od.nih.gov 

Dated: November 1, 2010. 

Jacqueline Corrigan-Curay, 

Acting Director, Office of Biotechnology 

Activities, National Institutes of Health. 

[FR Doc. 2010–28373 Filed 11–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Interagency Autism Coordinating 

Committee (IACC) Subcommittee on 

Safety. 

The Interagency Autism Coordinating 

Committee (IACC) Subcommittee on 

Safety will be meeting on Monday, 

November 29, 2010. The subcommittee 

plans to discuss issues related to autism 

and safety. This meeting will be open to 

the public and will be accessible 

through a conference call. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of Meeting: Subcommittee on Safety. 

Date: November 29, 2010. 

Time: 9 a.m. to 12 p.m. Eastern Time. 

Agenda: To discuss issues related to 

autism and safety. 

Place: The Neuroscience Center, 6001 

Executive Boulevard, Conference Room B1/ 

B2, Rockville, MD 20852. 

Conference Call Access: Dial: 800–369– 

1754. Access code: 5105457. 

Cost: The meeting is free and open to the 

public. 

Registration: http:// 

www.acclaroresearch.com/oarc/11–29–10/. 

Pre-registration is recommended to expedite 

check-in. Seating in the meeting room is 

limited to room capacity and on a first come, 

first served basis. 

Access: Metro accessible—White Flint 

Metro (Red Line). 

Contact Person: Ms. Lina Perez, Office of 

Autism Research Coordination, National 

Institute of Mental Health, NIH, 6001 

Executive Boulevard, NSC, Room 8185a, 

Rockville, MD 20852. Phone: 301–443–6040. 

E-mail: IACCPublicInquiries@mail.nih.gov. 

Please Note: 

The meeting will be open to the public and 

accessible through a conference call. 

Members of the public who participate using 

the conference call phone number will be 


emcdonald on DSK2BSOYB1PROD with NOTICES
69092 Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices 

able to listen to the meeting but will not be 

heard. If you experience any technical 

problems with the conference call, please email: 

IACCTechSupport@acclaroresearch.com. 

Individuals who participate in person or by 

using these electronic services and who need 

special assistance, such as captioning of the 

conference call or other reasonable 

accommodations, should submit a request to 

the Contact Person listed on this notice at 

least 7 days prior to the meeting. 

As a part of security procedures, attendees 

should be prepared to present a photo ID at 

the meeting registration desk during the 

check-in process. Pre-registration is 

recommended. Seating will be limited to the 

room capacity and seats will be on a first 

come, first served basis, with expedited 

check-in for those who are pre-registered. 

Please note: Online pre-registration will close 

by 5 p.m. the day before the meeting. After 

that time, registration will have to be done 

onsite the day of the meeting. 

Meeting schedule subject to change. 

Information about the IACC and a 

registration link for this meeting are available 

on the Web site: http//:www.iacc.hhs.gov. 

Dated: November 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28299 Filed 11–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel MBRS SCORE Meeting. 

Date: December 2–3, 2010. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Room 

3AN12, Bethesda, MD 20892. (Virtual 

Meeting) 

Contact Person: Lisa Dunbar, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN12, Bethesda, 

MD 20892. 301–594–2849. 

dunbarl@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: November 3, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28298 Filed 11–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel MBRS Behavioral Science Panel. 

Date: December 2, 2010. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Room 

3AN18, Bethesda, MD 20892. (Telephone 

Conference Call) 

Contact Person: Rebecca H. Johnson, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18C, Bethesda, 

MD 20892. 301–594–2771. 

johnsonrh@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: November 3, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28297 Filed 11–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive And Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, DDK–B Conflicts. 

Date: December 2, 2010. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. (Telephone 

Conference Call) 

Contact Person: Ann A. Jerkins, PhD, 

Scientific Review Officer, Review Branch, 

Dea, NIDDK, National Institutes of Health, 

Room 759, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452. 301–594–2242. 

Jerkinsa@Niddk.Nih.Gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, CKD And CVD 

Ancillary Studies. 

Date: December 17, 2010. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 


emcdonald on DSK2BSOYB1PROD with NOTICES